VLP 2.7MM EXTRA LARGE PERCUTANEOUS CALCANEUS PLATE, PERI-LOC 3.5MM ANTERIOR ANKLE FUSION PLATES, PERI-LOC 3.5MM HINDFOOT

K120667 · Smith & Nephew, Inc. · HRS · Apr 4, 2012 · Orthopedic

Device Facts

Record IDK120667
Device NameVLP 2.7MM EXTRA LARGE PERCUTANEOUS CALCANEUS PLATE, PERI-LOC 3.5MM ANTERIOR ANKLE FUSION PLATES, PERI-LOC 3.5MM HINDFOOT
ApplicantSmith & Nephew, Inc.
Product CodeHRS · Orthopedic
Decision DateApr 4, 2012
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3030
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Smith & Nephew VLP FOOT Plating System can be used in adolescent (12-18 years) and transitional adolescent (18-21 years) subpopulations and adults, as well as patients with osteopenic bone. The VLP FOOT Plating System is indicated for fracture fixation, reconstruction or arthrodesis of small bones, including those in the forefoot, midfoot and hindfoot. The Smith & Nephew PERI-LOC Ankle Fusion Plating System can be used in adolescent (12-18 years) and transitional adolescent (18-21 years) subpopulations and adults, as well as patients with osteopenic bone. The PERI-LOC Ankle Fusion Plating System is indicated for ankle arthrodesis and fractures, including the distal tibia, talus and calcaneus.

Device Story

Implantable locking bone plates and device-specific instruments; manufactured from stainless steel. Used by orthopedic surgeons in clinical settings for bone fixation, reconstruction, or arthrodesis. Plates provide mechanical stabilization of bone fractures or fusion sites. Device-specific instruments facilitate surgical implantation. Benefits include structural support for healing small bones and ankle joints. Single-use only.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Implantable locking bone plates and associated instruments. Material: implant-grade stainless steel. Design: various lengths (67mm-104mm) with compression slots. Intended for internal fixation. Sterilization: not specified (standard for orthopedic implants).

Indications for Use

Indicated for fracture fixation, reconstruction, or arthrodesis of small bones (forefoot, midfoot, hindfoot) and ankle arthrodesis/fractures (distal tibia, talus, calcaneus). Patient population includes adolescents (12-18), transitional adolescents (18-21), and adults, including those with osteopenic bone.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K120667 # 510(k) Summary of Safety and Effectiveness # PERI-LOC Ankle Fusion Bone Plates. VLP 2.7mm Extra Large Percutaneous Calcaneus Plate and Device Specific Instrument 4 2012 Submitted By: Date: Smith & Nephew, Inc. Orthopaedics 1450 Brooks Road Memphis, TN 38116 March 2, 2012 David Henley, Regulatory Affairs Project Manager Tel: (901) 399-6487 Fax: (901) 566-7079 PERI-LOC Ankle Fusion Bone Plates, VLP 2.7mm Extra Large Percutaneous Calcaneus Plate and Device Specific Instrument Common Name: Contact Person: Proprietary Name: Classification Name and Reference: Device Product Code and Panel Code: Bone Plates 21 CFR 888.3030, Single/multiple component metallic bone fixation appliances and accessories - Class II HRS / Orthopedics / 87 #### Device Description: The subject devices are comprised of implantable, locking bone plates and a device specific instrument. All described implants are manufactured from implant grade stainless steel material. The subject implant devices are available in the following sizes: | Device Type | Available Length | |------------------------------------------------------------------------------------------|------------------| | PERI-LOC 3.5mm Ankle Fusion Plates, Anterior Primary,<br>LH/RH with Compression Slot, 3H | 67mm | | PERI-LOC 3.5mm Ankle Fusion Plates, Anterior Primary,<br>LH/RH with Compression Slot, 5H | 92mm | | PERI-LOC 3.5mm Hindfoot Ankle Fusion Utility Plates,<br>LH/RH with Compression Slot, 5H | 104mm | | VLP 2.7mm Percutaneous Calcaneus Plates, Extra Large, LH/RH | 68mm | A new device specific instrument is also described in this Special 510(k) premarket notification in select sections and exhibits. # Intended Use: The Smith & Nephew VLP FOOT Plating System can be used in adolescent (12-18 years) and transitional adolescent (18-21 years) subpopulations and adults, as well as patients with osteopenic {1}------------------------------------------------ bone. The VLP FOOT Plating System is indicated for fracture fixation, reconstruction or arthrodesis of small bones, including those in the forefoot, midfoot and hindfoot. The Smith & Nephew PERI-LOC Ankle Fusion Plating System can be used in adolescent (12-18 years) and transitional adolescent (18-21 years) subpopulations and adults, as well as patients with osteopenic bone. The PERI-LOC Ankle Fusion Plating System is indicated for ankle arthrodesis and fractures, including the distal tibia, talus and calcaneus. ### Technological Characteristics: The PERI-LOC Ankle Fusion Plates and VLP Extra Large Percutaneous Calcaneus Plate are very similar to legally marketed devices cleared under K110670. When compared to the predicates from K110670, the proposed devices share identical indications for use and intended use, are manufactured from identical materials, and incorporate identical or very similar technological design characteristics. The device specific instrument described in this premarket notification is also very similar to the predicate device specific instruments cleared under K110670. ### Substantial Equivalence Information: When compared to the predicate implant and device specific instrument devices cleared under the premarket notification listed below, substantial equivalence is based on similarities with regard to overall indications for use, material composition, and technological design characteristics. - · VLP FOOT Plating System and PERI-LOC Ankle Fusion Plating System Locking Bone Plates and Screws and Device Specific Instruments - K110670 To further support a determination of substantial equivalence, a pre-clinical evaluation was conducted on the PERI-LOC Ankle Fusion Plates described in this premarket notification. Results were compared against previously cleared PERI-LOC Ankle Fusion Plate predicate devices described above and cleared under K110670. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized depiction of an eagle with its wings spread, symbolizing protection and care. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged around the eagle in a circular fashion. #### Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Smith & Nephew % Mr. David Henley Regulatory Affairs Project Manager 1450 Brooks Road Memphis, TN 38116 APR - 4 2012 Re: K120667 Trade/Device Name: PERI-LOC Ankle Fusion Bone Plates, VLP 2.7mm Extra Large Percutaneous Calcaneus Plate and Device Specific Instrument Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: II Product Code: HRS Dated: March 2, 2012 Received: March 5, 2012 Dear Mr. Henley: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 {3}------------------------------------------------ # Page 2 - Mr. David Henley CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours. ~Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Premarket Notification Indications for Use Statement 510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________ Device Name: PERI-LOC Ankle Fusion Plates and VLP Extra Large Percutaneous Calcaneus Plate Indications for Use: The Smith & Nephew PERI-LOC Ankle Fusion Plating System can be used in the Smith & 10 mm (10 millional odsleenent (18,21 years) subpopular The Smith & Nepliew I LINECOO Allike Frasitional adolescent (18-21 years) subpopulations adolescent (12-18 years) and transitional adolescent (18-21 years) subpopulations adolescent (12-10 years) and transitional anie boom. The PER-LOC Ankle Fusion and adults, as well as patients with osteopend from the distal and adults, as well as patients with occopyine befores, including the distal tibia, talus and calcaneus. The Smith & Nephew VLP FOOT Plating System can be used in adolescent (12-18) The Smith & Nepher (110-11-11) Start and outpanylations and edults, as well ine Smith & Nephew VEF | OO f 18-21 years) subpopulations and adults, as well years) and transitional adoloosins (10 ECP FOOT Plating System is indicated for as patients with Osteopenie bone. THE views of small bones, including those in the forefoot, midfoot and hindfoot. PERI-LOC Ankle Fusion Bone Plates and the VLP Extra Large Percutaneous Calcaneus Plate are for single use only. Prescription Use (Per 21 CFR 801.109) Over-the-Counter Use (Optional Format 1-2-96) (PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED) OR Concurrence of CDRH, Office of Device Evaluation (ODE) Signature (Division Sign-Oft) Division of Surgical, Orthopedic, and Restorative Devices 510(k) Number K122667
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...